Indevus Pharmaceuticals (NasdaqNM:IDEV)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Indevus Pharmaceuticals (NasdaqNM:IDEV)

An SI Board Since September 2003

Posts	SubjectMarks	Bans	Symbol
78	14	0	IDEV

Emcee: SemiBull	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
53	FDA approval announced...one down and more more FDA decision pending for 2007.	Arthur Radley	-	5/3/2007
52	With closing of the buyout next week I think the stock will move because the cap	Arthur Radley	-	4/9/2007
51	Results of PIII Supprelin-LA trial published: robust efficacy and safety bodes w	invbiotech	-	4/2/2007
50	With news today and FDA action later this year for their other drug, IMO this st	Arthur Radley	-	3/26/2007
49	IDEV price target: $17 Indevus Pharmaceuticals, Inc. IDEV – $6.71 Buy Price Tar	invbiotech	-	2/12/2007
48	5-Feb-07 Punk, Ziegel & Co Initiated Buy	Arthur Radley	-	2/5/2007
47	A large sale by some 10% owners: secform4.com	idos	-	1/7/2007
46	Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation	invbiotech	-	1/5/2007
45	FDA Accepts New Drug Application for SANCTURA XR(TM) Submitted by Indevus Wednes	invbiotech	-	12/13/2006
44	Indevus Pharmaceuticals to Acquire Valera Pharmaceuticals Tuesday December 12, 7	invbiotech	-	12/12/2006
43	Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensin	invbiotech	-	12/5/2006
42	Indevus Announces Licensing and Manufacturing Pact for SANCTURA XR(TM) With Mada	invbiotech	-	11/6/2006
41	Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM)	FiloF	-	7/7/2006
40	Will it retest 5 and be a buy soon?	Astroid23	-	3/21/2006
39	Indevus Licenses U.S. Rights to NEBIDO(R) from Schering AG, Germany 29 July 2005	FiloF	-	7/29/2005
38	Indevus Announces Positive Phase II Results for Sanctura XR; Trial Supports Phas	FiloF	-	6/15/2005
37	UK Government Funding Granted for Phase III Safety and Effectiveness Trial of PR	scaram(o)uche	-	4/6/2005
36	NIH Initiates International Microbicide Trial Including Pro 2000 11 February 200	FiloF	-	2/11/2005
35	Chuckle. Yeah, let's throw all medicines away and start over.	scaram(o)uche	-	10/7/2004
34	Well I hope nobody has a migraine while using Sanctura. Just like that I will ow	Don Hurst	-	10/7/2004
33	When you have a history like Indevus, a little investor scepticism isn't ent	nigel bates	-	10/7/2004
32	Nigel, this stock has an incredible ability to resist any positive gain due to o	Don Hurst	-	10/6/2004
31	Indevus Initiates Multi-Dose Phase I Clinical Trial of Aminocandin for Systemic	nigel bates	-	10/6/2004
30	Richard, interesting stuff.....from now on I am going to forward all my question	Don Hurst	-	8/30/2004
29	IDEV is Interneuron, Interneuron was a "Rosenwald company", and it beh	scaram(o)uche	-	8/30/2004

Go to reply# or date (mm/dd/yy):